A global dialogue as part of the dementia landscape project series will gather international leaders on 10 November 2021 to discuss the priorities and challenges faced by early career research scientists working in the field of dementia.
A global dialogue as part of the dementia landscape project series will gather international leaders, who have lived experience of dementia, on 1 November 2021 to discuss the important policy priorities from their individual perspectives.
A global dialogue as part of the dementia landscape project series will gather international leaders on 26 October 2021 to discuss social and psychosocial research in dementia.
A global dialogue as part of the dementia landscape project series will gather international leaders on 21 October 2021 to explore future approaches to the development of disease modifying treatments in non-amyloid targets.
The WDC is delighted to announce that four new individuals have been appointed to join the Council.
Professor Paulo Caramelli obtained his MD in 1987 at the University of São Paulo (USP) School of Medicine, in São Paulo, Brazil and completed the residency program in Neurology at the Hospital das Clínicas of the USP School of Medicine in 1991. Research fellow at the University of Montréal, Canada, from 1992 to 1994. In 1997, he completed a PhD in Neurological Sciences at the USP School of Medicine.
Hilary Evans is Chief Executive of Alzheimer’s Research UK (ARUK), the UK’s leading dementia research charity. ARUK is committed to investigating the causes of dementia and developing ways to prevent, diagnose, treat and, ultimately, cure all forms of the condition. As Chief Executive since 2015, Hilary has led the transformation of the charity to one of the leading medical research charities in the UK. She has overseen a significant growth in income in recent years, with ARUK being one of the fastest growing UK charities.
Professor Brian Lawlor is Professor of Old Age Psychiatry at Trinity College Dublin and Deputy Executive Director of the Global Brain Health Institute based at Trinity College Dublin and University of California San Francisco. His main clinical and research interests are in the diagnosis and treatment of Alzheimer’s disease, behavioural and psychological symptoms of dementia and on the impact of loneliness on the brain health and wellbeing of older people.
Howard Bergman MD, FCFP, FRCPC, FCAHS, C.Q.
Howard Bergman is Professor of Family Medicine, Medicine (Geriatrics) and Oncology in the Faculty of Medicine and Health Sciences at McGill University, where he is also a Professor in the School of Population and Global Health.